{"id":"https://genegraph.clinicalgenome.org/r/ed22e019-2c09-4d6c-9b0e-edc4553d9f44v1.0","type":"EvidenceStrengthAssertion","dc:description":"","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ed22e019-2c09-4d6c-9b0e-edc4553d9f44","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2018-01-23T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f12c33e-488f-46d5-9862-bcc47e8d8e85","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1020f271-aca0-4761-81d5-91d719cdb140","type":"Finding","dc:description":"Undetectable SCAD activity, severe organic aciduria; excreting ethylmalonic and methylsuccinic acids and N-butyrylglycine, and develop a fatty liver upon fasting or dietary fat challenge. The mutant mice develop hypoglycemia after an 18-h fast, and have elevated urinary and muscle butyrylcarnitine concentrations. Similar to human phenotypes of elevated ethylmalonic acid and  butyrylcarnitine (C4) concentrations found in most patients, even those without further clinical symptoms. This mouse models severe human disease. It  should be noted that the molecular mechanism is slightly different then seen in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2919115","rdfs:label":"BALB/cByJ mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31cf1250-6561-4c4a-9ba9-3d3fb170046a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e6f8157-df9c-4d6f-a897-38b52f4b24c4","type":"Finding","dc:description":"This RNA-seq is in normal tissue","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"ACADS: HPA RNA-Seq Normal tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/c6bc94e9-cdf2-4efb-b654-004541efc344_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e64fa24-eb73-46d6-a92d-4d079c70883b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Probable founder variant. FAO Expert Group decided to score one homozygous proband at max points (1.5) and all other curated homozygous probands at 0.5 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5aae373a-7020-47b8-88f3-e616afb478cc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18676165","rdfs:label":"Case 2","ageType":"AgeAtDiagnosis","ageUnit":"Days","ageValue":19,"detectionMethod":"Referenced the sequencing protocol from  Corydon et al. 2001 PMID:11134486","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"ethylmalonic aciduria","phenotypes":"obo:HP_0003219","previousTesting":true,"previousTestingDescription":"None, acquired through positive newborn screen","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4e64fa24-eb73-46d6-a92d-4d079c70883b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18676165","allele":{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.319C>T (p.Arg107Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3826"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c08dbffd-77fd-43e8-a25b-c2ea49f78ef4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3122eb0d-d307-4755-896f-e663d69ad186","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","rdfs:label":"Proband 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Probands pooled from multiple sources. Most likely detection method is candidate gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c08dbffd-77fd-43e8-a25b-c2ea49f78ef4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a1758932-f7d9-4db0-b46d-7f7e1d9caed0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.136C>T (p.Arg46Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3825"}},{"id":"https://genegraph.clinicalgenome.org/r/2aef1ad6-380c-4d3c-b93f-a85079aa12ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.120738618C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA386601286"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2d3e1326-98c6-4e2e-9bb1-712a7a304e36_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5d644b5-0662-4112-bc41-fd0bf3383cfa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20376488","rdfs:label":"Subject 2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ethylmalonic aciduria, no clinical symptoms","phenotypes":"obo:HP_0003219","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2d3e1326-98c6-4e2e-9bb1-712a7a304e36_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20376488","allele":[{"id":"https://genegraph.clinicalgenome.org/r/3ca5fe97-f264-4bdd-a368-edabefcc9357","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.164C>T (p.Pro55Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/30611"}},{"id":"https://genegraph.clinicalgenome.org/r/12b2f998-ff2b-4bc2-aec1-15d7be288d66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.323G>A (p.Gly108Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/30613"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e8d0dec2-82bc-4369-a180-4b3abd8e2d8c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"NM_000017.3(ACADS):c.511C>T (p.Arg171Trp) was considered too common in the general population (gnomAD total MAF = 0.03138) to be eligible for scoring by the ClinGen Fatty Acid Oxidation Expert Group","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc9a896e-20a9-4717-befe-5c0ca458490a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9499414","rdfs:label":"Patient 1","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":5,"detectionMethod":"Direct PCR, no other molecular testing noted","firstTestingMethod":"PCR","phenotypeFreeText":"At 3 months (onset), coughing, vomiting and poor feeding  (diagnosed with bronchopneumonia  ) Presented  again at 5 months, hypotonia and low level of consciousness. EMA 126 mmol/mol creatine. Normal growth/ development at 4yrs","phenotypes":["obo:HP_0003219","obo:HP_0011968","obo:HP_0008947","obo:HP_0002013"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e8d0dec2-82bc-4369-a180-4b3abd8e2d8c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9499414","allele":[{"id":"https://genegraph.clinicalgenome.org/r/32231cfe-3f1e-4ad0-aa19-acfd6602d893","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.1147C>T (p.Arg383Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3829"}},{"id":"https://genegraph.clinicalgenome.org/r/194a604d-b203-4435-aec3-67417967ef7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.511C>T (p.Arg171Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3830"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8e2e3258-1ec6-41da-88ef-768df33932e0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef76c74a-cc10-4769-9fc0-9bd148218e69","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1692038","rdfs:label":"YH2065","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Used PCR to amplify the entire cDNA synthesized from total RNA from patient derived fibroblasts. No other genes were investigated.","firstTestingMethod":"PCR","phenotypeFreeText":"Metabolic acidosis, early episode of lethargy","phenotypes":["obo:HP_0001254","obo:HP_0001942"],"previousTesting":true,"previousTestingDescription":"No known previous testing.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e2e3258-1ec6-41da-88ef-768df33932e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1692038","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a1758932-f7d9-4db0-b46d-7f7e1d9caed0"},{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded"}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c3a1640e-015d-460a-99b0-7f5c38188bcb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Probable founder variant. FAO Expert Group decided to score one homozygous proband at max points (1.5) and all other curated homozygous probands at 0.5 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7b0b638-50b9-46a3-be88-ac5f027c890e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054510","rdfs:label":"E460-1","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"Direct sequencing of  gene specific PCR product only","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"hypotonia, multiminicore myopathy, ethylmalonic aciduria, facial weakness. \n\nAlso noted Also noted sutural cataracts and opthalmoplegia (HPOs not listed)","phenotypes":["obo:HP_0010628","obo:HP_0003789","obo:HP_0003219","obo:HP_0008947"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c3a1640e-015d-460a-99b0-7f5c38188bcb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054510","allele":{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7b679c3e-2348-41ec-8f1b-385b3dff59c8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63336b6e-6814-412a-b314-f57baa0f19f3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","rdfs:label":"Proband 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Probands pooled from multiple sources. Most likely detection method is candidate gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7b679c3e-2348-41ec-8f1b-385b3dff59c8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7ff828f5-30d2-410e-b59d-26ccadc32d32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.120737960C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6830940"}},{"id":"https://genegraph.clinicalgenome.org/r/fcb8eb3c-350f-4310-8817-d935330938c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.120737412G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6830880"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4e8a917e-593c-42de-827c-585fb11a2b40_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe5b8695-de36-4b6f-b45c-da7b21efba48","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11134486","rdfs:label":"Patient 3","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":1,"detectionMethod":"Direct (Sanger) sequencing of all exons and flanking intron sequences","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Presented with hypotonia, seizures, developmental delay, EMA excretion increased. **The HPO term for seizures was not included as the type of seizure was unspecified**","phenotypes":["obo:HP_0003219","obo:HP_0008947","obo:HP_0001263"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4e8a917e-593c-42de-827c-585fb11a2b40_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11134486","allele":[{"id":"https://genegraph.clinicalgenome.org/r/24c23afa-401b-46a6-9c52-50e0cb00a2f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.973C>T (p.Arg325Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3835"}},{"id":"https://genegraph.clinicalgenome.org/r/974f88bb-a98c-45e1-bd8e-ad88901bb29d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.575C>T (p.Ala192Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3834"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1fd4492a-9546-4f1d-93d1-2ab47a4ee610_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6747745b-427a-42ba-b282-45586614c4ef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","rdfs:label":"Proband 5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Probands pooled from multiple sources. Most likely detection method is candidate gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1fd4492a-9546-4f1d-93d1-2ab47a4ee610_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","allele":[{"id":"https://genegraph.clinicalgenome.org/r/28b09845-a109-437c-8fe7-0110790b684c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.529T>C (p.Trp177Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3828"}},{"id":"https://genegraph.clinicalgenome.org/r/4110332d-7ca8-4c96-a8d8-015e8495bb76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.120739440C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA244495699"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b083f4fd-a25b-414d-9806-b37d0f965a5c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8fdfece-6476-406c-a924-603f1eea5a24","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20376488","rdfs:label":"Subject 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ethylmalonic aciduria, no clinical symptoms","phenotypes":"obo:HP_0003219","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b083f4fd-a25b-414d-9806-b37d0f965a5c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20376488","allele":[{"id":"https://genegraph.clinicalgenome.org/r/563d8964-181e-4f4c-b292-6cf89958783d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.1031A>G (p.Glu344Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/30612"}},{"id":"https://genegraph.clinicalgenome.org/r/3ca5fe97-f264-4bdd-a368-edabefcc9357"}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8dd0942a-24c1-45f2-b7d8-6d8ddc1a8c66_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b0520fc-60f1-432b-8a14-2524cc502634","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","rdfs:label":"Proband 4","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Probands pooled from multiple sources. Most likely detection method is candidate gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8dd0942a-24c1-45f2-b7d8-6d8ddc1a8c66_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","allele":{"id":"https://genegraph.clinicalgenome.org/r/396f4131-49ad-4234-b997-e2d4a5b0d75c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.1138C>T (p.Arg380Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3837"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e7843225-2ee7-4119-a387-730156fb9ab5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Probable founder variant. FAO Expert Group decided to score one homozygous proband at max points (1.5) and all other curated homozygous probands at 0.5 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05910d90-5c80-442d-9d6c-3c5e735a5572","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054510","rdfs:label":"E365","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"detectionMethod":"Direct sequencing of  gene specific PCR product only","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Developmental delay, speech delay, hypotonia, facial weakness.","phenotypes":["obo:HP_0008947","obo:HP_0001263","obo:HP_0010628","obo:HP_0000750"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7843225-2ee7-4119-a387-730156fb9ab5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054510","allele":{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9b937688-27e8-4ce6-94ff-74a8fa796458_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Probable founder variant. FAO Expert Group decided to score one homozygous proband at max points (1.5) and all other curated homozygous probands at 0.5 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fd842cd-ddd7-42cf-9659-feea0e80fb63","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18676165","rdfs:label":"Case 4","ageType":"AgeAtDiagnosis","ageUnit":"Days","ageValue":10,"detectionMethod":"Referenced the sequencing protocol from  Corydon et al. 2001 PMID:11134486","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ethylmalonic aciduria, recurrent diarrhea, vomiting","phenotypes":["obo:HP_0003219","obo:HP_0002028","obo:HP_0002013"],"previousTesting":true,"previousTestingDescription":"None, acquired through positive newborn screen","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b937688-27e8-4ce6-94ff-74a8fa796458_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18676165","allele":{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/258aa6b7-2c9d-4f09-a635-c8d22dd33bbb_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/525db51a-f04f-468b-bfb7-3c582da75fb6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","rdfs:label":"Proband 2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Probands pooled from multiple sources. Most likely detection method is candidate gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/258aa6b7-2c9d-4f09-a635-c8d22dd33bbb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","allele":[{"id":"https://genegraph.clinicalgenome.org/r/43d28cd5-7c05-40e4-af9a-43b6d8a8d8d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.1095G>T (p.Gln365His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA312228"}},{"id":"https://genegraph.clinicalgenome.org/r/fcb8eb3c-350f-4310-8817-d935330938c4"}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7ba5b91b-f262-4abd-bf22-a481d41f3ae5_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c64a7cc4-452e-4167-8443-b3461723dcf5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9499414","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"Direct PCR, no other molecular testing noted","firstTestingMethod":"PCR","phenotypeFreeText":"presented at 1 day with a \"shaking-starting spell\", unable to determine relevant HPO term.  \n\n“Strikingly abnormal” EMA (3900 mmol/mol creatine)","phenotypes":"obo:HP_0003219","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7ba5b91b-f262-4abd-bf22-a481d41f3ae5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9499414","allele":[{"id":"https://genegraph.clinicalgenome.org/r/28b09845-a109-437c-8fe7-0110790b684c"},{"id":"https://genegraph.clinicalgenome.org/r/1b6cff52-87f3-4b1b-8766-917cfcbcfd1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000017.3(ACADS):c.274G>T (p.Gly92Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3827"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6367ac92-03f6-412f-a9f4-ba4beb62faf0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Very strong experimental variant evidence supporting pathogenicity. Probable founder variant, FAO Expert Group decided to score one homozygous proband at max points (1.5) and all other curated homozygous probands at 0.5 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f175eb6d-fdec-4d68-908d-5018daf50be8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054510","rdfs:label":"E486","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"Direct sequencing of  gene specific PCR product only","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Hypotonia, developmental delay, myopathy  (Unspecified, no HPO was added for curation), speech delay, lethargy, feeding difficulties,   EMA 65-222, C4 elevated","phenotypes":["obo:HP_0008872","obo:HP_0000750","obo:HP_0003219","obo:HP_0001263","obo:HP_0001254","obo:HP_0008947"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6367ac92-03f6-412f-a9f4-ba4beb62faf0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054510","allele":{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/22cc076f-ffc4-4db3-8b23-d1a155475d10_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8d27d25-082d-4495-817a-1c38b3c7a97e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18676165","rdfs:label":"Case 3","ageType":"AgeAtDiagnosis","ageUnit":"Days","ageValue":10,"detectionMethod":"Referenced the sequencing protocol from  Corydon et al. 2001 PMID:11134486","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"ethylmalonic aciduria","phenotypes":"obo:HP_0003219","previousTesting":true,"previousTestingDescription":"None, acquired through positive newborn screen","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/22cc076f-ffc4-4db3-8b23-d1a155475d10_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18676165","allele":{"id":"https://genegraph.clinicalgenome.org/r/28b09845-a109-437c-8fe7-0110790b684c"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9c33ca41-c073-45ca-8a0a-2ad5a4f101b4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Probable founder variant. FAO Expert Group decided to score one homozygous proband at max points (1.5) and all other curated homozygous probands at 0.5 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4084fca7-123f-4549-ac1f-6d36e5e16351","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","rdfs:label":"Proband 6","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Probands pooled from multiple sources. Most likely detection method is candidate gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9c33ca41-c073-45ca-8a0a-2ad5a4f101b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18523805","allele":{"id":"https://genegraph.clinicalgenome.org/r/73e5ccd1-27a9-4902-81f7-03d1f9d19ded"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":213,"specifiedBy":"GeneValidityCriteria6","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/TICRHVhySUQ","type":"GeneValidityProposition","disease":"obo:MONDO_0008722","gene":"hgnc:90","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c6bc94e9-cdf2-4efb-b654-004541efc344-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}